Analyst Activity – JPMorgan Chase & Co. Initiates Coverage On Celgene (NASDAQ:CELG) With a Overweight

Analyst Ratings For Celgene (NASDAQ:CELG)

Story continues below

Today, JPMorgan Chase & Co. initiated coverage on Celgene (NASDAQ:CELG) with a Overweight with a price target of $88.27.

Some recent analyst ratings include

  • 3/21/2018-JPMorgan Chase & Co. initiated coverage with a Overweight rating.
  • 3/1/2018-Robert W. Baird Reiterated Rating of Hold.
  • 2/28/2018-William Blair Reiterated Rating of Buy.
  • 2/28/2018-Stifel Nicolaus Reiterated Rating of Buy .
  • 2/28/2018-SunTrust Banks was Downgraded by analysts at SunTrust Banks from a “Buy ” rating to a ” Hold” rating. They now have a $106.00 price target on the stock, up previously from $139.00 .

Recent Insider Trading Activity For Celgene (NASDAQ:CELG)
Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 78.60%.

  • On 3/12/2018 James J Loughlin, Director, sold 9,250 with an average share price of $92.01 per share and the total transaction amounting to $851,092.50.
  • On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
  • On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
  • On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
  • On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
  • On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
  • On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.

Recent Trading Activity for Celgene (NASDAQ:CELG)
Shares of Celgene closed the previous trading session at with shares trading hands.

An ad to help with our costs